IRIS
BERTINO, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.887
EU - Europa 5.143
AS - Asia 4.591
SA - Sud America 990
AF - Africa 582
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 7
Totale 21.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.527
SG - Singapore 2.617
RU - Federazione Russa 1.711
CN - Cina 1.308
IT - Italia 1.063
IE - Irlanda 868
BR - Brasile 861
UA - Ucraina 787
CI - Costa d'Avorio 405
CA - Canada 301
VN - Vietnam 219
GB - Regno Unito 127
DE - Germania 123
SE - Svezia 120
IN - India 98
SN - Senegal 79
KR - Corea 73
FR - Francia 47
PL - Polonia 47
AR - Argentina 46
FI - Finlandia 45
NL - Olanda 43
MX - Messico 38
BD - Bangladesh 32
HK - Hong Kong 32
TR - Turchia 32
ZA - Sudafrica 31
UZ - Uzbekistan 28
AT - Austria 27
BE - Belgio 26
ES - Italia 26
JP - Giappone 24
CZ - Repubblica Ceca 21
IQ - Iraq 21
EC - Ecuador 19
CH - Svizzera 18
MA - Marocco 18
ID - Indonesia 17
CO - Colombia 15
GR - Grecia 14
IR - Iran 14
KE - Kenya 13
VE - Venezuela 12
EU - Europa 10
NG - Nigeria 10
PK - Pakistan 10
SA - Arabia Saudita 10
PE - Perù 9
PY - Paraguay 9
BJ - Benin 8
CL - Cile 8
IL - Israele 7
LT - Lituania 7
NP - Nepal 7
QA - Qatar 7
UY - Uruguay 7
AU - Australia 6
BG - Bulgaria 6
LB - Libano 6
AE - Emirati Arabi Uniti 5
KZ - Kazakistan 5
PA - Panama 5
AO - Angola 4
JM - Giamaica 4
JO - Giordania 4
RO - Romania 4
ET - Etiopia 3
GA - Gabon 3
HN - Honduras 3
HR - Croazia 3
MY - Malesia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
EG - Egitto 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NA - Namibia 1
NZ - Nuova Zelanda 1
Totale 21.206
Salva come PNG Salva come JPEG
Città #
Dallas 2.039
Singapore 1.491
Santa Clara 1.132
Dublin 864
Chandler 747
Moscow 701
Jacksonville 691
San Jose 421
Abidjan 405
Chicago 402
Boardman 349
Ashburn 332
Los Angeles 271
Nanjing 248
Lawrence 241
Andover 239
Cambridge 238
Toronto 225
Beijing 196
Catania 190
Hefei 173
Houston 148
Des Moines 126
Wilmington 99
San Mateo 98
Civitanova Marche 97
Dakar 79
New York 75
Shenyang 75
São Paulo 75
Seoul 73
Ho Chi Minh City 71
Nanchang 69
Saint Petersburg 65
Buffalo 63
Council Bluffs 61
Milan 56
Hebei 54
Changsha 51
Hanoi 47
Ottawa 46
Bremen 45
The Dalles 45
Tianjin 44
Jiaxing 42
Mountain View 41
Palermo 41
Columbus 38
Rome 38
Brooklyn 37
Warsaw 36
Hong Kong 32
Dong Ket 29
Orem 28
Munich 27
Belo Horizonte 26
Brussels 26
Kochi 25
Tokyo 24
Chennai 23
Johannesburg 23
Mascalucia 23
Rio de Janeiro 22
Turku 21
Amsterdam 19
Atlanta 19
London 19
Montreal 19
Mumbai 19
Denver 18
Boston 17
Manchester 17
Stockholm 17
Norwalk 16
Phoenix 16
Brasília 15
Falls Church 15
Gravina di Catania 15
Redondo Beach 15
Lappeenranta 14
Naples 14
Redmond 14
Baghdad 13
Seattle 13
Brno 12
Foggia 12
Jinan 12
Leawood 12
Poplar 12
Pune 12
San Francisco 12
Tashkent 12
Washington 12
Guarulhos 11
Kunming 11
Mexico City 11
Modica 11
Porto Alegre 11
Abuja 10
Charlotte 10
Totale 14.366
Salva come PNG Salva come JPEG
Nome #
Malattie dell'apparato digerente. Edizione 2025-2028 242
A study about mechanism of des-gamma-carboxy prothrombin’s production in hepatocellular carcinoma 205
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 200
Carbohydrate 19.9 Antigen Serum Levels in Liver Disease 195
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 188
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 183
Anorectal mucosal melanoma 183
Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer 170
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 169
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 164
Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study 163
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results 161
Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications? 159
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives 155
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 154
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis 153
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 152
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance 146
High carbohydrate 19-9 antigen serum levels in patients with nonmelanoma skin cancer and primary occult cancer 146
Hepatocellular carcinoma serum markers 143
Acetyl-L-carnitine can slow the progression from prefrailty to frailty in older subjects. A randomized interventional clinical trial 141
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 141
Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis 141
Evaluation of health status in patients with hepatitis c treated with and without interferon 137
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis 136
An unusual case of HBV reactivation in a patient with cholangitis and choledocho-lithiasis undergone to ERCP. A case report 135
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis 135
Obesity and related diseases: an epidemiologic study in Eastern Sicily 133
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. 133
Eterozigosi H36D per Emocromatosi in pazienti affetti da Steatoepatite e Epatite cronica da virus C 133
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature 131
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 129
Circulating adhesion molecules in patients with virus-related chronic diseases of the liver 128
Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients 126
A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C 126
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study 125
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension 125
A phase IIIb, 2X2 factorial, double blind study of 48 versus 96 weeks of peg-Interferon alpha 2a 180 micrg, with or without 24 weeks of Entecavir in adult patients with HbeAg negative chronic hepatitis B 124
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis 123
Rare benign tumors of the liver: still rare? 121
Possibile associazione di anemia normocromica con maggiore incremento delle molecole di adesione ICAM-2 e VCAM-1 in pazienti con cirrosi epatica: studio pilota 119
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic epatiti C treated with pegylated interferon α and ribavirin 119
Biochemical long-term outcomes in chronic hepatitis C patients treated with a twelve months course of alpha lymphoblastoid interferon 118
Carbohydrate 19-9 antigen in chronic viral hepatitis without neoplasia is associated with the severity of liver disease 118
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 117
Carnitine Serum Levels in Frail Older Subjects 117
Type II Mixed Cryoglobulinemia In Patients With Hepatitis C Virus: Treatment with Pegylated-Interferon and Ribavirin 115
Hepatocellular carcinoma and the risk of occupational exposure. 113
Laparoscopic Reversal of Hartmann's Procedure: State of the Art 20 Years after the First Reported Case 112
Behavior of alpha-1-antitrypsin in adults with chronic liver disease 110
Systemic Therapies in Hepatocellular carcinoma: present and future 110
Giant cavernous liver hemangiomas: is it the time to change the size categories? 110
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study 110
Resveratrol in Patients with Minimal Hepatic Encephalopathy 109
Circulating erytropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study 108
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 108
AIDS. Sindrome da Immunodeficienza Acquisita 108
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 108
Eritropoietina nel trattamento dell'anemia secondaria a terapia con interferone peghilato e ribavirina 107
Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability 105
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 105
Hepatocellular Carcinoma 104
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 103
Trattamento con peg-interferone e ribavirina nell’epatite cronica attiva C ed insorgenza di malattia celiaca: esiste una relazione ? 103
Chronic anaemia and adhesion molecules in patients with liver cirrhosis. A preliminary report 102
Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina 102
Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype 102
Rosuvastatin reduces non alcoholic fatty liver diseasa in patients with chronic hepatitis C treated with alpha-interferon and ribavirin 101
Epatite cronica: un caso di sovrapposizione epatite autoimmune-epatite virale 100
Telbivudine on-treatment HBsAg loss in naïve HBeAg negative chronic hepatitis B: A case report and brief review of the literature 99
Does follow-up offer the best quality of life for patients affected by so-called 'giant' haemangiomas of the liver? 97
Obesity as a Confounding Factor in the Diagnosis of Wilson’s Disease: Case Report of Two Siblings with the Same Genotype but Different Clinical Courses 96
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 96
ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B 95
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 95
Trattamento dell'epatite cronica B, HBeAg negativa, con terapia di combinazione: Adefovir e Interferone-Pegilato alfa 2a vs Adefovir (Studio PAC: Peg Adefovir Combination) 94
REAL-WORLD DATA ON LONG TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS: FIRST RELEASE FROM THE ITALIAN RECAPITULATE STUDY 93
Digestive diseases. 2022-2025 edition 93
Combined duodenal and pancreatic major trauma in high risk patients: can a partial reconstruction be safe? 93
Co-administration ezetimibe/simvastatin teraphy decrease the supersaturation in gallbladder bile and prevent cholesterol gallstones formation 92
Totally Implantable Venous Access Devices: Efforts Are Needed to Standardize Procedures to Avoid Complications 92
Current practice of chronic hepatitis B treatment in Southern Italy 91
Endozepine-4 levels are increased in hepatic coma. 91
Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment 90
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata 90
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania 89
Vaccinazione anti-epatite B: differenze della risposta immune con Hevac B Pasteur in rapporto all'età 89
Chronic hepatitis C: This and the new era of treatment 88
INFEZIONE DA HAV IN PAZIENTI CON EPATITE CRONICA HCV-CORRELATA 88
Hepatocellular Carcinoma: present and future 88
CO-ADMINISTRATION EZETIMIBE/SIMVASTATIN TERAPHY DECREASES THE SUPER-SATURATION IN GALLBLADDER BILE AND PREVENT CHOLESTEROL GALLSTONES FORMATION 87
POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 87
Ferro e ferrodeplezione nell'epatite cronica HCV-correlata.Studio pilota 86
Potential role of probiotics on colorectal cancer prevention 86
Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments 86
Hepatocellular carcinoma markers in the omics era: the glycomic analysis 86
Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study 85
COMPLICATION AND HOSPITALISATION AFTER PERCUTANEOUS LIVER BIOPSY: A COHORT STUDY OF 12 YARS 85
La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata 84
Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS) 83
Totale 12.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021601 0 0 0 0 0 0 159 18 102 60 183 79
2021/20221.735 222 279 20 27 267 14 255 55 137 6 62 391
2022/20232.609 257 97 40 229 241 442 17 449 673 25 79 60
2023/20241.222 69 162 45 56 49 264 24 91 13 41 230 178
2024/20254.856 77 754 306 226 1.002 549 150 190 343 539 346 374
2025/20267.967 611 556 2.235 619 1.561 1.900 485 0 0 0 0 0
Totale 21.818